We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BMKDF market cap is 13.77M. The company's latest EPS is CAD -0.0157 and P/E is -9.55.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 263k | 0 | 44k | 153k | 163k |
| Operating Income | -703k | -554k | -719k | -1.21M | -1.81M |
| Net Income | -1.22M | -1.09M | -1.45M | -1.84M | -1.43M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 637k | 952k | 1.47M | 732k | 1.09M |
| Total Liabilities | 1.08M | 1.03M | 2.11M | 1.88M | 1.7M |
| Total Equity | -439k | -80k | -636k | -1.15M | -609k |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -454k | -457k | -1.2M | -915k | -983k |
| Investing | -1,000 | -3k | -59k | -5k | -4k |
| Financing | 1.05M | 725k | 769k | 609k | 1.07M |
| Market Cap | 13.77M |
| Price to Earnings Ratio | -9.55 |
| Price to Sales Ratio | 83.33 |
| Price to Cash Ratio | 88.24 |
| Price to Book Ratio | -22.39 |
| Dividend Yield | - |
| Shares Outstanding | 90.89M |
| Average Volume (1 week) | 300 |
| Average Volume (1 Month) | 28.18k |
| 52 Week Change | -18.11% |
| 52 Week High | 0.2303 |
| 52 Week Low | 0.12476 |
| Spread (Intraday) | 0.08 (46.31%) |
| Company Name | Biomark Diagnostics Inc (PK) |
| Address |
130 - 3851 shell rd richmond, british columbia V6X 2W2 |
| Website | https://www.biomarkdiagnostics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
